Transformative education: Enhancing pharmacovigilance awareness among healthcare professionals through sensitization initiatives

变革性教育:通过宣传活动提高医护人员的药物警戒意识

阅读:1

Abstract

BACKGROUND: Pharmacovigilance plays a vital role in patient safety by identifying, assessing, and preventing adverse drug reactions (ADRs). Despite its importance, pharmacovigilance awareness among healthcare professionals often remains limited, leading to underreporting of adverse drug reactions and compromising patient safety. Educational interventions offer a potential solution to enhance pharmacovigilance knowledge and a reporting practice. AIMS: To evaluate the effectiveness of an educational intervention in improving knowledge and ADR reporting behaviours among healthcare professionals. METHODS AND MATERIAL: A questionnaire-based pre- and post-intervention design was used, involving health care providers. This study was conducted in three sessions on different dates, with a stipulated time of 2 hour at a tertiary care hospital. Participants attended 2-hour educational session about awareness of pharmacovigilance knowledge, attitude, and practices. A 20-items questionnaire was used to assess about pharmacovigilance awareness before and after educational intervention. STATISTICAL ANALYSIS: Data were analysed using IBM SPSS 27 version software, employing a paired t-test to measure changes in scores. RESULTS: Post-intervention participants had a statistically significant increase in pharmacovigilance knowledge, improved attitude towards ADR reporting, and greater confidence in reporting practices. However, limitations such as the lack of a control group and short follow-up duration suggest that further research is needed to confirm long-term impacts. CONCLUSIONS: Educational intervention is effective in enhancing Pharmacovigilance awareness among health care providers. Further studies should include a control group and longer follow-up to better understand the sustained impact of such an intervention. Integrated regular pharmacovigilance training within healthcare institutions and simplifying ADR reporting can further improve medication safety and patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。